GIP, on the other hand, is secreted by K cells of the small intestine
Months 36: Consistent Progress During this period, weight loss becomes more predictable and steady
By controlling entry, facilities maintain a high standard of hygiene, security, and compliance with GMP regulations throughout the manufacturing process
The image below highlights the mechanisms of both GLP-1 and GIP, along with a callout to the newest treatment optiona triple incretin that also includes glucagonexpected to be approved in late 2025 to early 2026
Many users also notice improved sleep, recovery, and cognitive clarity after consistent use
Considering the widespread expression of GLP-1 receptors in the brain, the authors recommend that future studies should focus on identifying the key neurocircuits involved in mediating the effects of GLP-1 receptor agonists on substance use disorder, as well as determine the specific patient subtypes who are most likely to benefit from these treatments